Flow cytometric analysis of human PBMC labelling Mouse CD160 antibody at 1/200 dilution (1 μg) / (Right panel) compared with a Mouse IgM, κ Isotype Control / (Left panel). Goat Anti-Mouse IgG Alexa Fluor® 488 was used as the secondary antibody. Then cells were stained with CD56 - APC Antibody separately.
Product Details
Product Details
Product Specification
| Host | Mouse |
| Antigen | CD160 |
| Synonyms | CD160 antigen; Natural killer cell receptor BY55; BY55 |
| Location | Cell membrane |
| Accession | O95971 |
| Clone Number | S-3866 |
| Antibody Type | Mouse mAb |
| Isotype | IgM,k |
| Application | FCM |
| Reactivity | Hu |
| Positive Sample | Human PBMC |
| Concentration | 2 mg/ml |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS pH7.4 |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
| application | dilution | species |
| FCM | 1:200 | Hu |
Background
CD160 is a glycosylphosphatidylinositol-anchored cell surface receptor of the immunoglobulin superfamily, expressed on subsets of CD4⁺ and CD8⁺ T cells, γδ T cells, NK cells and NKT cells, that binds classical and non-classical MHC-I molecules (HLA-C, -A, -E, -F) and herpesvirus entry mediator (HVEM) to deliver potent inhibitory or activating signals depending on cellular context; engagement on CD8⁺ T cells triggers PI3K-dependent survival and cytotoxic granule release, whereas on NK cells it enhances cytotoxicity and IFN-γ production, and its soluble form (sCD160) generated by metalloprotease shedding acts as a decoy receptor that limits angiogenesis and tumor growth, making CD160 a key checkpoint regulator of antiviral, antitumor and autoimmune responses.
Picture
Picture
FC
